Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience

被引：2
|
作者：
Cassanello, G. [1 ]
Serpenti, F. [1 ]
Bagnoli, F. [2 ]
Saporiti, G. [3 ]
Goldaniga, M. [3 ]
Cavallaro, F. [3 ]
Barbullushi, K. [1 ]
Bellani, V. [1 ]
Galassi, G. [3 ]
Onida, F. [1 ,3 ]
机构：
[1] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Human Canc Ctr, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 09期
关键词：
INDEX;
D O I：
10.1038/s41409-023-02023-2
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1059 / 1061
页数：3
相关论文
共 50 条
  • [1] Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
    G. Cassanello
    F. Serpenti
    F. Bagnoli
    G. Saporiti
    M. Goldaniga
    F. Cavallaro
    K. Barbullushi
    V. Bellani
    G. Galassi
    F. Onida
    Bone Marrow Transplantation, 2023, 58 : 1059 - 1061
  • [2] TREOSULFAN, THIOTEPA AND FLUDARABINE CONDITIONING REGIMEN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER EXPERIENCE
    Cassanello, Giulio
    Bagnoli, Filippo
    Saporiti, Giorgia
    Goldaniga, Maria
    Serpenti, Fabio
    Cavallaro, Francesca
    Barbullushi, Kordelia
    Galassi, Giulia
    Barcellini, Wilma
    Onida, Francesco
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 264 - 265
  • [3] Thiotepa-treosulfan-fludarabine (ttf) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation (allohsct) for myelofibrosis or myelodysplastic syndrome: A single center experience
    Canale, F. A.
    Porto, G.
    Provenzano, P. F.
    Naso, V.
    Moscato, T.
    Pugliese, M.
    Loteta, B.
    Irrera, G.
    Console, G.
    Ferreri, A.
    Martino, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 236 - 236
  • [4] Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients
    Baronciani, Donatella
    Rambaldi, Alessandro
    Iori, Anna Paola
    Di Bartolomeo, Paolo
    Pilo, Federica
    Pettinau, Martina
    Depau, Cristina
    Mico, Caterina
    Santarone, Stella
    Angelucci, Emanuele
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (09) : 717 - 720
  • [5] Reduced intensity conditioning regimen with treosulfan for second allogeneic stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome. A single-centre experience
    Stevkova, J.
    Visek, B.
    Lanska, M.
    Zavrelova, A.
    Doskocilova, K.
    Radocha, J.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 179 - 180
  • [6] Allogeneic blood stem cell transplantation of high-risk patients after conditioning with treosulfan and fludarabine
    Casper, J
    Wilhelm, S
    Steiner, B
    Wolff, D
    Grobe, N
    Hähling, D
    Hartung, G
    Hilgendorf, I
    Lück, A
    Junghanss, C
    Kahl, C
    Baumgart, J
    Pichlmeier, U
    Freund, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (38) : 2125 - 2129
  • [7] Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes
    Shimoni, Avichai
    Hardan, Izhar
    Shem-Tov, Noga
    Rand, Avital
    Yerushalmi, Ronit
    Nagler, Arnon
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2352 - 2359
  • [8] The Efficacy and Safety of Busulfan Dose Intensity with Fludarabine Conditioning Regimen for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation. A Single Center Experience
    Massoud, Radwan
    Heller, Raban
    Moukalled, Nour
    Matar, Charbel
    Haffar, Basel
    Bazarbachi, Ali
    El-Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S310 - S311
  • [9] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    BLOOD, 2003, 102 (11) : 711A - 711A
  • [10] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Jens Marcus Chemnitz
    Marie von Lilienfeld-Toal
    Udo Holtick
    Sebastian Theurich
    Alexander Shimabukuro-Vornhagen
    Anke Krause
    Peter Brossart
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2012, 91 : 47 - 55
12345